This book provides a fresh, multidisciplinary, and exciting look at the making and remaking of pharmaceutical patents at the GATT/WTO, by utilising a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin focuses on the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement and consequently, the role of the African Group at the WTO in the remaking of those patent provisions.
Integrating newcomers and minorities into the social fabric of receiving countries has become one of the crucial challenges of contemporary Western societies. This volume seeks to understand patterns of changing institutional practices and public policies where the challenges of including cultural diversity into the social fabric are most pronounced: namely the health care system. In recent years, pro-migrant organizations and anti-racist activists have repeatedly voiced and politicized demands to improve migrants' access to the health-care system giving rise to a lively debate about migrants' access to health-care and responsiveness of institutions to their needs. In a nutshell the book achieves the following: - Provides a conceptual framework to link patterns of political advocacy/mobilization and processes of migrants' socio-political inclusion - Integrates the (multi-disciplinary) literature on political mobilization and accommodating cultural diversity in an innovative fashion - Presents a comparative study on accommodating diversity in the health care system from a comparative transatlantic perspective - Generates insight into best practices in the health care system that will be of interest to scholars as well as practitioners in the field. The analysis of health care provision offers an opportunity to test new public policy strategies and the policy consequences of the now widespread aspiration to include citizens more fully in designing and implementing them.
Hein and Moon take up a serious problem of contemporary global governance: what can be done when international trade rules prevent the realization of basic human rights? Starting in the 1990s, intellectual property obligations in trade agreements required many developing countries to begin granting medicines patents, which often rendered lifesaving drugs unaffordable. At stake was the question of what priority would be given to health-particularly of some of the world’s poorest people-and what priority to economic interests, particularly those of the most powerful states and firms. This book recounts the remarkable story of the access to medicines movement. The authors offer an explanation for how the informal, but powerful norm that every person should have access to essential medicines emerged after a decade of heated political contestation and against long odds. They also explore the stability and scope of the norm. Finally, the book examines the limitations of informal norms for protecting human rights, and when renewed focus on changing formal norms is warranted.
This book provides a fresh, multidisciplinary, and exciting look at the making and remaking of pharmaceutical patents at the GATT/WTO, by utilising a Coxian political economy of continuity and change in the global political economy (GPE). Marcellin focuses on the role of the transnational drug industry in the making of the patent provisions in the original TRIPS Agreement and consequently, the role of the African Group at the WTO in the remaking of those patent provisions.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.